Biohit Oyj — Director's Dealing 2022

Jan 18, 2022

Biohit Oyj - Managers' Transactions - Söderström

Biohit Oyj - Managers' Transactions - Söderström

Person subject to the notification requirement
Name: Daniela Söderström
Position: Other senior manager

Issuer: Biohit Oyj
LEI: 74370089ATTSNBXJVT29
Notification type: INITIAL NOTIFICATION
Reference number: 9306/4/6
____________________________________________

Transaction date: 2022-01-13
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021A
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 8000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 8000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-13
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021B
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 8000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 8000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-13
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021C
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 8000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 8000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-13
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021D
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 8000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 8000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-13
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021E
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 8000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 8000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-13
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021A
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 10000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 10000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-13
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021B
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 10000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 10000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-13
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021C
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 10000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 10000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-13
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021D
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 10000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 10000 Volume weighted average price: 0 EUR

CEO Päivi Siltala, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com (https://eur04.safelinks.protection.outlook.com/?url=htt
p%3A%2F%2Fwww.biohithealthcare.com%2F&data=04%7C01%7CSanna.Kurlin%40biohit.fi%7Ce
79379bd970246069f0608d9d50d0c93%7C4da67d2fc92245f9b72584364b1decf5%7C0%7C0%7C6377
75074284926203%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTi
I6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=GgUivFiD2ZOAtSif14toy%2Fyj%2FqHKdd1Vm2vTRJ4
0I4E%3D&reserved=0)

Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology
company. Biohit’s mission is “Innovating for Health” – we produce innovative
products and services to promote research and early diagnosis. Biohit is
headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK.
Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small
cap/Healthcare group. www.biohithealthcare.com

Attachments: